(19)

(11)

EP 1 474 103 A1

(12)

(43) Date of publication: 10.11.2004 Bulletin 2004/46 (21) Application number: 02706298.3 (22) Date of filing: 15.02.2002

(51) International Patent Classification (IPC)7: A61K 9/00, A61K 9/20, A61K 9/44, A61K 9/38, A61K 31/195, A01N 37/12, A01N 37/44 (86) International application number: PCT/US2002/004665 (87) International publication number: WO 2003/070217 (28.08.2003 Gazette 2003/35)

(84) Designated Contracting States: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR Designated Extension States: AL LT LV MK RO SI (71) Applicant: King Pharmaceuticals, Inc. Bristol, TN 37620 (US)	(72) Inventors: FRANZ, Andrew G. St. Louis, MO 63124 (US) STRAUSS, Elaine A. Seminole, FL 33776 (US) DIMENNA, Phillip A. St. Petersburg, FL 33710 (US) GEMMA, Rocco L. Dover, OH 44622 (US) (74) Representative: Arends, William Gerrit et al Lloyd WiseCommonwealth House1-19 New Oxford Street London WC1A 1LW London WC1A 1LW (GB)